Home › Trial NCT05634564
Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer
- Trial IDNCT05634564
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Enrollment62
- Start date2020-06-01
- ConditionsPancreatic Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.